TrialJournal of clinical pharmacology2025
Intranasal Naloxone During Recurrent Exercise in Individuals with Type-1 Diabetes Mellitus: Evaluation of the Clinical Predictors of Pharmacokinetics and Exposure-Response.
Omar N Al Yacoub et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.